1Department of Medicine, Endocrinology and Metabolism, University of Heidelberg, Heidelberg, Germany. henning-woitge@med.uni-heidelberg.de
Molecular markers are crucial for assessing metabolic bone diseases, aiding in fracture risk evaluation and treatment monitoring. However, clinical application requires careful consideration of patient complexity and marker variability.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: